Detalhe da pesquisa
1.
Stepwise optimization of tumor-targeted dual-action platinum(iv)-gemcitabine prodrugs.
Inorg Chem Front
; 11(2): 534-548, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235273
2.
Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs.
Inorg Chem Front
; 10(14): 4126-4138, 2023 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440920
3.
Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands.
Pharmaceutics
; 15(2)2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36839999
4.
Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter ABCA7 in Breast Cancer.
Cells
; 12(11)2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296582
5.
The Lipid Metabolism as Target and Modulator of BOLD-100 Anticancer Activity: Crosstalk with Histone Acetylation.
Adv Sci (Weinh)
; 10(32): e2301939, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752764
6.
The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation.
Pharmaceutics
; 14(2)2022 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213972
7.
Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands.
J Med Chem
; 64(16): 12132-12151, 2021 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34403254